Literature DB >> 11145001

Neurotrophic effects of FPF-1070 (Cerebrolysin) on cultured neurons from chicken embryo dorsal root ganglia, ciliary ganglia, and sympathetic trunks.

T Satou1, T Itoh, Y Tamai, H Ohde, A J Anderson, S Hashimoto.   

Abstract

We examined the effect of FPF-1070 (Cerebrolysin) on neurite outgrowth in explant cultures of dorsal root ganglia (DRG), sympathetic trunks (ST), and ciliary ganglia (CG) from 10- to 11-day chicken embryos. FPF-1070 significantly promoted neurite outgrowth in DRG and ST neurons at all concentrations examined, in comparison with phosphate buffered saline-treated negative controls; however, this effect on neurite outgrowth was not as significant as that observed for nerve growth factor-treated positive controls on DRG and ST neurons. Additionally, FPF-1070 exhibited an inverted U relationship between concentration and effectiveness in DRG and ST neurons. In contrast, FPF-1070 did not affect neurite outgrowth in CG neurons although ciliary neurotrophic factor-treated positive controls showed striking neurite outgrowth. Our results demonstrate that FPF-1070 has different neurotrophic effects depending on the subpopulation of neurons. This study clarifies a role for neurotrophic activity in the mechanism of action of FPF-1070.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11145001     DOI: 10.1007/s007020070015

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  12 in total

1.  Neuroprotection of cerebrolysin in tissue culture models of brain ischemia: post lesion application indicates a wide therapeutic window.

Authors:  E Schauer; R Wronski; J Patockova; H Moessler; E Doppler; B Hutter-Paier; M Windisch
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

2.  Probable Nootropicinduced Psychiatric Adverse Effects: A Series of Four Cases.

Authors:  Farid Talih; Jean Ajaltouni
Journal:  Innov Clin Neurosci       Date:  2015 Nov-Dec

3.  Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial.

Authors:  W Poon; C Matula; P E Vos; D F Muresanu; N von Steinbüchel; K von Wild; V Hömberg; E Wang; T M C Lee; S Strilciuc; J C Vester
Journal:  Neurol Sci       Date:  2019-09-07       Impact factor: 3.307

4.  Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease.

Authors:  Edward Rockenstein; Kiren Ubhi; Emiley Pham; Sarah Michael; Edith Doppler; Philipp Novak; Chandra Inglis; Michael Mante; Anthony Adame; X Anton Alvarez; Herbert Moessler; Eliezer Masliah
Journal:  J Neurosci Res       Date:  2011-07-25       Impact factor: 4.164

Review 5.  Cerebrolysin: a review of its use in dementia.

Authors:  Greg L Plosker; Serge Gauthier
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

6.  Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndrome.

Authors:  Edith Doppler; Edward Rockenstein; Kiren Ubhi; Chandra Inglis; Michael Mante; Anthony Adame; Leslie Crews; Monika Hitzl; Herbert Moessler; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2008-07-04       Impact factor: 17.088

7.  Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral artery.

Authors:  Dragos Catalin Jianu; Dafin Fior Muresanu; Ovidiu Bajenaru; Bogdan Ovidiu Popescu; Sanda Maria Deme; Herbert Moessler; Sibilla Zimmermann Meinzingen; Ligia Petrica; Ligia Petria
Journal:  J Med Life       Date:  2010 Jul-Sep

8.  Ciliary neurotrophic factor promotes motor reinnervation of the musculocutaneous nerve in an experimental model of end-to-side neurorrhaphy.

Authors:  Petr Dubový; Otakar Raška; Ilona Klusáková; Lubomír Stejskal; Pavel Celakovský; Pavel Haninec
Journal:  BMC Neurosci       Date:  2011-06-22       Impact factor: 3.288

9.  Cerebrolysin administration reduces oxidative stress-induced apoptosis in lymphocytes from healthy individuals.

Authors:  Patrizia Formichi; Elena Radi; Carla Battisti; Giuseppe Di Maio; Dafin Muresanu; Antonio Federico
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

10.  Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke.

Authors:  Won Hyuk Chang; Chang-hyun Park; Deog Young Kim; Yong-Il Shin; Myoung-Hwan Ko; Ahee Lee; Shin Yi Jang; Yun-Hee Kim
Journal:  BMC Neurol       Date:  2016-03-02       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.